admin
September 22, 2021
TEVA PHARMACEUTICALS INTERNATIONAL GMBH, Appellant, v. ELI LILLY AND COMPANY, Appellee ANDREW HIRSHFELD, PERFORMING THE FUNCTIONS AND DUTIES OF THE UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenor 2020-1747, 2020-1748, 2020-1750 Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board […]
admin
March 26, 2018
Merck Sharp & Dohme Corp., v. Amneal Pharmaceuticals LLC No. 2017-1560 Fed. Cir. Feb. 9 2018 Opinion by Circuit Judge Stoll with Circuit Judges Taranto and Clevenger. Merck filed an infringement suit alleging that, if approved by the FDA, Amneal’s proposed Abbreviated New Drug Application (“ANDA”) product would infringe U.S.Patent No. 6,127,353. Following a bench trial, the district court […]
admin
May 26, 2017
Novartis AG v. Noven Pharmaceuticals Inc. No. 2016-1678, -1679 Fed. Cir. Apr. 4, 2017 Opinion by Circuit Judge Wallach with Chief Judge Prost and Circuit Judge Stoll Editors note: The instant appeals concern inter partes reviews of U.S. Patent Nos. 6,316,023 (“the ’023 patent”) and 6,335,031 (“the ’031 patent”) (together, “the Patents-in-Suit”). The United States Court of Appeals […]
admin
March 26, 2017
SHIRE DEVELOPMENT, LLC, SHIRE PHARMACEUTICAL DEVELOPMENT, INC., COSMO TECHNOLOGIES LIMITED, GIULIANI INTERNATIONAL LIMITED, NKA NOGRA PHARMA LIMITED, Plaintiffs-Appellees v. WATSON PHARMACEUTICALS, INC., NKA ACTAVIS, INC., WATSON LABORATORIES, INC. – FLORIDA, NKA ACTAVIS LABORATORIES FL, INC., WATSON PHARMA, INC., NKA ACTAVIS PHARMA, INC., WATSON LABORATORIES, INC., Defendants-Appellants 2016-1785 February 10, 2017 Plaintiffs Shire sued Defendants Watson […]
admin
November 26, 2016
MIT v. Shire Pharmaceuticals, Inc. No. 2015-1881 Fed. Cir. Oct. 13, 2016 Opinion by Circuit Stoll with Circuit Judges O’Malley and Chen. The issues on appeal are: 1) the district court’s claim construction of “vascularized organ tissue” and “cells derived from a vascularized tissue” in view of the prosecution history; and 2) the district court’s […]
